BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Riches JC. Impact of COVID-19 in patients with lymphoid malignancies. World J Virol 2021; 10(3): 97-110 [PMID: 34079692 DOI: 10.5501/wjv.v10.i3.97]
URL: https://www.wjgnet.com/2307-8960/full/v10/i3/97.htm
Number Citing Articles
1
Samuel M. Rubinstein, Divaya Bhutani, Ryan C. Lynch, Chih-Yuan Hsu, Yu Shyr, Shailesh Advani, Ruben A. Mesa, Sanjay Mishra, Daniel P. Mundt, Dimpy P. Shah, R. Alejandro Sica, Keith E. Stockerl-Goldstein, Catherine Stratton, Matthias Weiss, Alicia Beeghly-Fadiel, Melissa Accordino, Sarit E. Assouline, Joy Awosika, Ziad Bakouny, Babar Bashir, Stephanie Berg, Mehmet Asim Bilen, Cecilia A. Castellano, Jacob C. Cogan, Devendra KC, Christopher R. Friese, Shilpa Gupta, Daniel Hausrath, Clara Hwang, Nathalie A. Johnson, Monika Joshi, Anup Kasi, Elizabeth J. Klein, Vadim S. Koshkin, Nicole M. Kuderer, Daniel H. Kwon, Chris Labaki, Tahir Latif, Eric Lau, Xuanyi Li, Gary H. Lyman, Rana R. McKay, Gayathri Nagaraj, Amanda Nizam, Taylor K. Nonato, Adam J. Olszewski, Hyma V. Polimera, Andrew J. Portuguese, Matthew M. Puc, Pedram Razavi, Rachel Rosovski, Andrew Schmidt, Sumit A. Shah, Aditi Shastri, Christopher Su, Pallawi Torka, Trisha M. Wise-Draper, Leyre Zubiri, Jeremy L. Warner, Michael A. Thompson. Patients Recently Treated for B-lymphoid Malignancies Show Increased Risk of Severe COVID-19Blood Cancer Discovery 2022; 3(3): 181 doi: 10.1158/2643-3230.BCD-22-0013
2
Öner Özdemir. Effects of COVID-19 in lymphoid malignanciesWorld Journal of Virology 2021; 10(6): 329-331 doi: 10.5501/wjv.v10.i6.329
3
E. A. Pogodina, I. Zh. Shubina, A. V. Lobov, P. I. Ivanova, N. Yu. Sokolov. Antitumor immunotherapy and COVID-19 in cancer patientsRussian Journal of Biotherapy 2022; 21(2): 10 doi: 10.17650/1726-9784-2022-21-2-10-18
4
Yael Eshet, Abraham Avigdor, Meirav Kedmi, Noam Tau. Imaging of Hematological Patients in the Era of COVID-19Acta Haematologica 2022; 145(3): 267 doi: 10.1159/000522323
5
Irina Zh. Shubina, Irina O. Chikileva, Nikolay Yu. Sokolov. Cancer Treatment: An Interdisciplinary ApproachInterdisciplinary Cancer Research 2023; 2: 251 doi: 10.1007/16833_2022_100
6
Xuejun Alice Wang, Adam F. Binder, Usama Gergis, Lindsay Wilde. COVID-19 in Patients With Hematologic Malignancies: A Single Center Retrospective StudyFrontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.740320
7
Munerah Hamed, Doaa Alamoudi. Recurrent COVID-19 Infection in a Refractory/Classical Hodgkin's Lymphoma Patient Undergoing Autologous Stem Cell Transplantation: A Case ReportCureus 2023;  doi: 10.7759/cureus.46950
8
Catherine Mark, Sumit Gupta, Angela Punnett, Julia Upton, Julia Orkin, Adelle Atkinson, Lindsay Clarke, Alice Heisey, Christine McGovern, Sarah Alexander. Safety of administration of BNT162b2 mRNA (Pfizer‐BioNTech) COVID‐19 vaccine in youths and young adults with a history of acute lymphoblastic leukemia and allergy to PEG‐asparaginasePediatric Blood & Cancer 2021; 68(11) doi: 10.1002/pbc.29295
9
Gabriela Gama Freire Alberca, Ricardo Wesley Alberca. Role of vitamin D deficiency and comorbidities in COVID-19World Journal of Virology 2022; 11(1): 85-89 doi: 10.5501/wjv.v11.i1.85
10
E. A. Pogodina, A. V. Lobov, P. I. Ivanova, V. I. Kazey, I. Zh. Shubina. Induction of anti-SARS-CoV-2 immune reactions in immune compromised patientsRussian Journal of Biotherapy 2021; 20(4): 18 doi: 10.17650/1726-9784-2021-20-4-18-25
11
Tarun Sahu, Henu Kumar Verma, Bhaskar Lvks. Management of SARS-CoV-2 infection is a major challenge in patients with lymphoid malignancies: Warrants a clear therapeutic strategyWorld Journal of Virology 2022; 11(4): 204-207 doi: 10.5501/wjv.v11.i4.204